Literature DB >> 2903157

The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor.

S Cheifetz1, J L Andres, J Massagué.   

Abstract

The transforming growth factor-beta (TGF-beta) receptor type III is a low abundance cell surface component that binds TGF-beta 1 and TGF-beta 2 with high affinity and specificity, and is present in many mammalian and avian cell types. Type III TGF-beta receptors affinity-labeled with 125I-TGF-beta migrate in sodium dodecyl sulfate-polyacrylamide electrophoresis gels as diffuse species of 250-350 kDa. Here we show that type III receptors deglycosylated by the action of trifluoromethanesulfonic acid yield affinity-labeled receptor cores of 110-130 kDa. This marked decrease in molecular weight is also achieved by combined treatment of type III receptors with heparitinase and chondroitinase ABC. Digestion of receptor-linked glycosaminoglycans by treatment of intact cell monolayers with heparitinase and chondroitinase does not prevent TGF-beta binding to the type III receptor core polypeptide and does not release the receptor polypeptide from the membrane. The type III TGF-beta receptor binds tightly to DEAE-Sephacel and coelutes with cellular proteoglycans at a characteristically high salt concentration. Thus, the type III TGF-beta receptor has the properties of a membrane proteoglycan that carries heparan and chondroitin sulfate glycosaminoglycan chains. The binding site for TGF-beta appears to reside in the 100-120-kDa core polypeptide of this receptor. The type III receptor is highly sensitive to cleavage by trypsin. Trypsin action releases the glycosaminoglycan-containing domain of the receptor leaving a 60-kDa membrane-associated domain that contains the cross-linked ligand. A model for the domain structure of the TGF-beta receptor type III is proposed based on these results.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903157

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process.

Authors:  Y Takeuchi; T Matsumoto; E Ogata; Y Shishiba
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

2.  Betaglycan has multiple binding sites for transforming growth factor-beta 1.

Authors:  S Kaname; E Ruoslahti
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

3.  Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis.

Authors:  Sébastien Le Jan; Makoto Hayashi; Zsolt Kasza; Inger Eriksson; Joseph R Bishop; Irene Weibrecht; Johan Heldin; Katarina Holmborn; Lars Jakobsson; Ola Söderberg; Dorothe Spillmann; Jeffrey D Esko; Lena Claesson-Welsh; Lena Kjellén; Johan Kreuger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-16       Impact factor: 8.311

Review 4.  Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family.

Authors:  Sun Kyung Kim; Morkos A Henen; Andrew P Hinck
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-10

Review 5.  Bone turnover across the menopause transition : The role of gonadal inhibins.

Authors:  Kristy M Nicks; Tristan W Fowler; Nisreen S Akel; Daniel S Perrien; Larry J Suva; Dana Gaddy
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

6.  Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis.

Authors:  M C Pepin; M Beauchemin; J Plamondon; M D O'Connor-McCourt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

7.  The GTS1 gene, which contains a Gly-Thr repeat, affects the timing of budding and cell size of the yeast Saccharomyces cerevisiae.

Authors:  K Mitsui; S Yaguchi; K Tsurugi
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling.

Authors:  Y-S Jang; G-Y Seo; J-M Lee; H-Y Seo; H-J Han; S-J Kim; B-R Jin; H-J Kim; S-R Park; K-J Rhee; W-S Kim; P-H Kim
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

9.  Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade.

Authors:  V M Paralkar; R G Hammonds; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

10.  Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein.

Authors:  E J Mitchell; K Lee; M D O'Connor-McCourt
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.